Literature DB >> 1495691

Accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers.

G Rizzo1, D Arduini, C Romanini.   

Abstract

OBJECTIVES: To determine the growth patterns of the fetal heart and the development of cardiac function during gestation in fetuses of diabetic mothers, and to compare these findings with those of normal fetuses.
METHODS: Serial M-mode and Doppler echocardiographic recordings were made at 4-week intervals in 14 fetuses of well-controlled type I insulin-dependent diabetic mothers and in ten control fetuses at 20-36 weeks' gestation. The following variables were measured: interventricular septal thickness, left ventricular wall thickness, right ventricular wall thickness, ratio between the peak velocities during early passive ventricular filling and active atrial filling at the level of the atrioventricular valves, peak velocities, and time to peak velocity at the level of the ascending aorta and pulmonary artery.
RESULTS: In both groups of fetuses, all of the indices increased linearly with gestation. However, fetuses of diabetic mothers showed significant differences in the slope and intercept values for the function describing the growth of the interventricular septum (P less than or equal to .001) and the right and left ventricular wall thicknesses (P less than or equal to .01), resulting in accelerated cardiac growth. The function describing the development of the ratios between early and active ventricular filling showed differences in slope and intercept values at the level of both the mitral (P less than or equal to .001) and tricuspid valves (P less than or equal to .001), resulting in a lower rate of increase during diabetic pregnancy when compared with control fetuses. Significantly higher intercept values were found in the functions describing the increase of peak velocities in the aorta and pulmonary artery in fetuses of diabetic mothers (P less than or equal to .01), whereas the slopes were similar to those of control fetuses. No differences were found in the time to peak values between the groups of fetuses. No relationships were found between the echocardiographic results and the metabolic control of pregnancy or fetal characteristics.
CONCLUSIONS: This study suggests that strict maternal diabetes control does not exclude accelerated fetal cardiac growth and abnormal development of cardiac function.

Entities:  

Mesh:

Year:  1992        PMID: 1495691

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Assessment of Cardiac Function in Fetuses of Gestational Diabetic Mothers During the Second Trimester.

Authors:  Mehnaz Atiq; Anum Ikram; Batool M Hussain; Bakhtawar Saleem
Journal:  Pediatr Cardiol       Date:  2017-03-24       Impact factor: 1.655

2.  Cardiac vectors in the healthy human fetus: developmental changes assessed by magnetocardiography and realistic approximations of the volume conductor.

Authors:  R Tao; E A Popescu; W B Drake; M Popescu
Journal:  Physiol Meas       Date:  2013-04-22       Impact factor: 2.833

3.  Clinical and echographic features of in utero cardiac dysfunction in the recipient twin in twin-twin transfusion syndrome.

Authors:  N Zosmer; R Bajoria; E Weiner; M Rigby; J Vaughan; N M Fisk
Journal:  Br Heart J       Date:  1994-07

4.  Nesidioblastosis-associated hypoglycaemia presenting with prominent cardiac manifestations.

Authors:  A C Galizia; S Fava; R Foale
Journal:  Postgrad Med J       Date:  1996-04       Impact factor: 2.401

5.  Assessment of cardiac functions in fetuses of gestational diabetic mothers.

Authors:  Sevket Balli; Feyza Aysenur Pac; İbrahim Ece; Mehmet Burhan Oflaz; Ayse Esin Kibar; Ömer Kandemir
Journal:  Pediatr Cardiol       Date:  2013-06-19       Impact factor: 1.655

6.  Heart disease in infants of diabetic mothers.

Authors:  H Narchi; N Kulaylat
Journal:  Images Paediatr Cardiol       Date:  2000-04

7.  Adverse pregnancy outcomes in women with diabetes.

Authors:  Carlos Antonio Negrato; Rosiane Mattar; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2012-09-11       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.